Global Oncology Academy
The Global Oncology Academy (GOA) is an educational platform for physicians and other healthcare professionals involved in oncology. Its mission is to increase knowledge regarding the disease course of specific cancers and address key elements for successful management. The GOA series will also share the science around innovations in combination therapies, oncology strategies, and new developments.
For more information about GOA, visit www.globaloncologyacademy.org.
91-105 of 422
Addressing Barriers to CAR T Referral in R/R LBCL
Project Oncology®Addressing Barriers to CAR T Referral in R/R LBCL
Coordinating Care for mCSPC Patients Receiving Androgen Receptor Pathway Inhibitors
Project Oncology®Coordinating Care for mCSPC Patients Receiving Androgen Receptor Pathway Inhibitors
Choosing Between Neoadjuvant and Perioperative Strategies in NSCLC
Project Oncology®Choosing Between Neoadjuvant and Perioperative Strategies in NSCLC
Blood-Based Colorectal Cancer Screening: Where Do We Stand?
Clinician's RoundtableBlood-Based Colorectal Cancer Screening: Where Do We Stand?
Optimizing Multidisciplinary Care in Perioperative NSCLC
Project Oncology®Optimizing Multidisciplinary Care in Perioperative NSCLC
Managing AKT Inhibitor-Associated AEs in HR+/HER2- Advanced Breast Cancer
Project Oncology®Managing AKT Inhibitor-Associated AEs in HR+/HER2- Advanced Breast Cancer
- advertisement
Choosing the Right ARPI in Metastatic Castration-Sensitive Prostate Cancer
Project Oncology®Choosing the Right ARPI in Metastatic Castration-Sensitive Prostate Cancer
Improving CRC Screening Conversations in Primary Care
Clinician's RoundtableImproving CRC Screening Conversations in Primary Care
Improving CRC Screening Workflows: A PCP's Recommendations
Clinician's RoundtableImproving CRC Screening Workflows: A PCP's Recommendations
Urinary and Circulating Tumor DNA in Muscle-Invasive Bladder Cancer: NIAGARA Data
Project Oncology®Urinary and Circulating Tumor DNA in Muscle-Invasive Bladder Cancer: NIAGARA Data
Choosing the Right Treatment in ALK and ROS1-Positive NSCLC
Project Oncology®Choosing the Right Treatment in ALK and ROS1-Positive NSCLC
Real-World Cases in Squamous Cell Carcinoma of the Anal Canal Care
Project Oncology®Real-World Cases in Squamous Cell Carcinoma of the Anal Canal Care
- advertisement
Making Mechanism-Based Treatment Decisions in cGVHD
Project Oncology®Making Mechanism-Based Treatment Decisions in cGVHD
Getting Biomarker Testing Right in Non-Small Cell Lung Cancer Care
Project Oncology®Getting Biomarker Testing Right in Non-Small Cell Lung Cancer Care
Beyond the Colonoscopy: New Screening Guidelines for Colorectal Cancer
Project Oncology®Beyond the Colonoscopy: New Screening Guidelines for Colorectal Cancer







































































